Novel SARS-CoV-2 Omicron variants in İstanbul; Rapid Preponderance of BA.2 and BA.5.

Autor: Tuyji-Tok Y; Department of Medical Microbiology, İstanbul University-Cerrahpaşa School of Medicine, İstanbul, Turkey., Yücebağ E; Department of Medical Microbiology, İstanbul University-Cerrahpaşa School of Medicine, İstanbul, Turkey., Keleş AB; Department of Medical Microbiology, İstanbul University-Cerrahpaşa School of Medicine, İstanbul, Turkey., Kılınçarslan AC; Department of Medical Microbiology, İstanbul University-Cerrahpaşa School of Medicine, İstanbul, Turkey., Nohut OK; Fikret Biyal Central Research Laboratory, İstanbul University-Cerrahpaşa School of Medicine, İstanbul, Turkey., Salman-Yılmaz S; Department of Forensic Medicine and Forensic Sciences, İstanbul University-Cerrahpaşa School of Medicine, Istanbul, Turkey., Kuşkucu MA; Department of Medical Microbiology, İstanbul University-Cerrahpaşa School of Medicine, İstanbul, Turkey., Midilli K; Department of Medical Microbiology, İstanbul University-Cerrahpaşa School of Medicine, İstanbul, Turkey.
Jazyk: angličtina
Zdroj: Infectious diseases & clinical microbiology [Infect Dis Clin Microbiol] 2022 Sep 26; Vol. 4 (3), pp. 192-198. Date of Electronic Publication: 2022 Sep 26 (Print Publication: 2022).
DOI: 10.36519/idcm.2022.143
Abstrakt: Objective: In Turkey, the fourth wave of SARS-CoV-2 started in December 2021 and peaked in mid-January 2022. Afterward, peaks were seen in the number of COVID-19 cases because of Omicron BA.2 and BA.5 variants. Our study aimed to observe the prevalence and viral load-related transmissibility rates of the Omicron BA.2 and BA.5 variant infections in our region between January 21 and July 01, 2022, using an easy and cost-effective PCR screening method.
Methods: The frequency of BA.2 and BA.5 were determined by the two-stage allele-specific and drop-out RT-PCR method targeting NSP6 105-107del, spike 69-70del, and spike L452R mutation-specific primers. Transmissibility of the Omicron variants was assessed using cycle threshold (Ct) values (a proxy for SARS-CoV-2 viral load and infectivity). Also, using the next generation sequencing (NGS) method, existing mutations were analyzed by generating full-length sequences of the representative, randomly selected samples from the Omicron variants determined by PCR screening test.
Results: We defined the first case of BA.2 on January 19, 2022, in İstanbul University-Cerrahpaşa School of Medicine COVID-19 Molecular Diagnosis Laboratory. Following this, it was observed that BA.1 lost its dominance due to the increased transmissibility of BA.2. On May 5, we defined the first case of BA.5, and as of July this Omicron variant rapidly became preponderant, with a frequency of more than 85%. Compared with BA.1, BA.2 and BA.5 were associated with 2.82 (95% CI: 2.33-4.12) and 2.49 (95% CI: 2.16-3.55) fewer cycles, respectively, meaning higher transmissibility. As confirmed by the NGS results, it was concluded that screening with NSP6 105-107del, spike 69-70del and spike L452R mutation targeted PCR method, which is used uniquely in our hospital in Turkey, can be an easy and cost-effective method in the follow-up of Omicron variants.
Conclusion: The higher viral load detection in infections with BA.2 and BA.5 reflects a prolonged disease period, and increased transmissibility, so rapid expansion of these Omicron variants in Turkey is inevitable. Even though the prevalence of the Omicron variants in the population can be monitored in near real-time by the PCR screening method, more sequencing studies are needed for the early identification of new mutations that will emerge.
Competing Interests: The authors declare no conflict of interest.
(Copyright © 2024 Infectious Diseases and Clinical Microbiology.)
Databáze: MEDLINE
Externí odkaz: